Trial Profile
A phase II study of perifosine in patients with slow growing sarcomas
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2007
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 06 Mar 2007 New trial record.